High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial

The Effect of Advances in Lung-Cancer Treatment on Population Mortality

Nadia Howlader, Gonçalo Forjaz, Meghan J. Mooradian et al. · New England Journal of Medicine · 2020 · 1.7K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide

Andrew T. Turrisi, KyungMann Kim, Ronald H. Blum et al. · New England Journal of Medicine · 1999 · 1.5K citations · Full text

Medicine, Oncology, Radiation Oncology +11

Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Martin Früh, Dirk De Ruysscher, Sanjay Popat et al. · Annals of Oncology · 2013 · 613 citations · Full text

Medicine, Oncology, Surgery +14

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial

Corinne Faivre‐Finn, M. Snee, Linda Ashcroft et al. · The Lancet Oncology · 2017 · 570 citations · Full text

Medicine, Oncology, Radiation Oncology +15

The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals Regarding the Clinical Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the Tumor, Node, Metastasis Classification for Lung Cancer

Frances A. Shepherd, John Crowley, Paul Van Houtte et al. · Journal of Thoracic Oncology · 2007 · 547 citations

Medicine, Oncology, Surgery +14